Invivoscribe, Inc.

Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company`s offerings include research use only (RUO) assays, analyte specific reagents (ASRs), and nucleic acid controls essential for DNA and RNA manipulation in healthcare and research settings. Their next-generation sequencing (NGS) products facilitate high-throughput DNA analysis, instrumental in personalized medicine and modern healthcare transformation. Invivoscribe`s PCR-based assays are designed for fluorescence and gel detection, targeting crucial genetic markers like FLT3 mutations and B- and T-cell clonality, vital for diagnosing and treating various blood cancers.